These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10762587)

  • 1. Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives.
    Hutagalung R; Wilairatana P; Looareesuwan S; Brittenham GM; Gordeuk VR
    J Infect Dis; 2000 Apr; 181(4):1513-6. PubMed ID: 10762587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hemoglobin E trait on the severity of Falciparum malaria.
    Hutagalung R; Wilairatana P; Looareesuwan S; Brittenham GM; Aikawa M; Gordeuk VR
    J Infect Dis; 1999 Jan; 179(1):283-6. PubMed ID: 9841856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemisinin derivatives for treating uncomplicated malaria.
    McIntosh HM; Olliaro P
    Cochrane Database Syst Rev; 2000; 1999(2):CD000256. PubMed ID: 10796519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any artemisinin resistance in falciparum malaria?
    Treeprasertsuk S; Viriyavejakul P; Silachamroon U; Vannphan S; Wilairatana P; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):825-8. PubMed ID: 11414435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of early rising parasitemia in falciparum malaria treated with artemisinin derivatives.
    Silachamroon U; Phumratanaprapin W; Krudsood S; Treeprasertsuk S; Budsaratid V; Pornpininworakij K; Wilairatan P; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):50-6. PubMed ID: 11485095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
    Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of artemisinin derivatives on malaria transmissibility.
    Price RN; Nosten F; Luxemburger C; ter Kuile FO; Paiphun L; Chongsuphajaisiddhi T; White NJ
    Lancet; 1996 Jun; 347(9016):1654-8. PubMed ID: 8642959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria.
    Karbwang J; Bangchang KN; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Lancet; 1992 Nov; 340(8830):1245-8. PubMed ID: 1359318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.
    Sugiarto SR; Moore BR; Makani J; Davis TME
    Clin Infect Dis; 2018 Feb; 66(5):799-804. PubMed ID: 29370347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin derivatives for treating severe malaria.
    McIntosh HM; Olliaro P
    Cochrane Database Syst Rev; 2000; 1998(2):CD000527. PubMed ID: 10796551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed parasite clearance in a splenectomized patient with falciparum malaria who was treated with artemisinin derivatives.
    Le TA; Davis TM; Tran QB; Nguyen VP; Trinh KA
    Clin Infect Dis; 1997 Oct; 25(4):923-5. PubMed ID: 9356813
    [No Abstract]   [Full Text] [Related]  

  • 12. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.
    Meshnick SR; Taylor TE; Kamchonwongpaisan S
    Microbiol Rev; 1996 Jun; 60(2):301-15. PubMed ID: 8801435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemisinin antimalarials: mechanisms of action and resistance.
    Meshnick SR
    Med Trop (Mars); 1998; 58(3 Suppl):13-7. PubMed ID: 10212891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rational use of qinghaosu and its derivatives: what is the future of new compounds?
    Looareesuwan S; Wilairatana P
    Med Trop (Mars); 1998; 58(3 Suppl):89-92. PubMed ID: 10212910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of clinical studies on artemisinin derivatives in Thailand.
    Looareesuwan S
    Trans R Soc Trop Med Hyg; 1994 Jun; 88 Suppl 1():S9-11. PubMed ID: 8053034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria.
    Svensson US; Alin H; Karlsson MO; Bergqvist Y; Ashton M
    Eur J Clin Pharmacol; 2002 Aug; 58(5):339-51. PubMed ID: 12185558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the research of artemisinin-related antimalarials: an update.
    Woerdenbag HJ; Pras N; van Uden W; Wallaart TE; Beekman AC; Lugt CB
    Pharm World Sci; 1994 Aug; 16(4):169-80. PubMed ID: 7951130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors.
    Ittarat W; Pickard AL; Rattanasinganchan P; Wilairatana P; Looareesuwan S; Emery K; Low J; Udomsangpetch R; Meshnick SR
    Am J Trop Med Hyg; 2003 Feb; 68(2):147-52. PubMed ID: 12641403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
    Price R; van Vugt M; Phaipun L; Luxemburger C; Simpson J; McGready R; ter Kuile F; Kham A; Chongsuphajaisiddhi T; White NJ; Nosten F
    Am J Trop Med Hyg; 1999 Apr; 60(4):547-55. PubMed ID: 10348227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.